This retrospective study sought to report the spectrum of infections in a homogenous group of 39 patients who underwent implantation of the Thoratec paracorporeal ventricular assist device system (Thoratec Laboratories) in an emergency setting. Thirty-one of the 39 patients developed a total of 99 nosocomial infections (attack rate, 79.5%; incidence, 4.9 per 100 support-days). The lungs were the most frequently involved site (31.3%), and coagulase-negative Staphylococcus species were the pathogens most frequently isolated (16.2%). Infected patients required more transfusions and chest surgical revisions, as well as a longer duration of mechanical ventilation and a longer stay in the intensive care unit, compared with uninfected patients. Cox regression analysis revealed that chest surgical revision was the only independent risk factor for infection at any site (odds ratio, 2.6; 95% confidence interval, 1.2-5.7). There was no significant effect of infection on heart transplantation rate and overall survival.
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According to a recent report, mechanical support results in a clinically meaningful survival benefit and an improved quality of life for patients with advanced heart failure [1] . However, long-term support with a ventricular assist device (VAD) is impeded by frequent life-threatening complications, including infections, bleeding, and thromboembolism [2, 3] . These complications seem to be interrelated and are associated with increased morbidity [4, 5] . Infection limits the effectiveness of circulatory support and poses an important threat to VAD recipients. The frequency, cause, site, and outcome of infections that complicate VAD support can vary widely, depending on the characteristics of the device [5] . In the present report, we review the post-fined using criteria from the US Centers for Disease Control and Prevention (Atlanta, GA) [6] . Moreover, all infections in this series were laboratory confirmed. Poststernotomy mediastinitis (PSM) was defined as deep sternal wound infection [7] . Diagnosis of cannula and chest drainage tube infections required association of local signs of infection at the access site with isolation of a compatible pathogen. Central venous catheter-related bloodstream infections were defined by isolation of the same organism (identical species and antibiogram) from a quantitative culture (with use of vortex with a threshold of cfu/mL) of a catheter segment and from the blood of a 3 10 patient with associated clinical symptoms of bloodstream infection and no other obvious source of infection. Diagnosis of nosocomial pneumonia was based on the association of systemic signs of infection, new or worsening infiltrates on chest radiographs, and bacteriologic evidence of pulmonary parenchymal infection with nonbronchoscopic techniques (e.g., sampling of distal airways by protected telescoping catheter) or bronchoscopic techniques (e.g., protected specimen brush or bronchoalveolar lavage). Concerning coagulase-negative staphylococcal bloodstream infections, у2 positive blood culture results were required to avoid contaminants. Cytomegalovirus infection was defined by the presence of signs and/or symptoms of disease combined with isolation of virus in the blood (i.e., blood infection), bronchoalveolar lavage fluid (i.e., lung infection), or any other body fluid or tissue specimen. Septic shock was diagnosed according to the 1992 consensus criteria of the American College of Chest Physicians [8] .
Surgical technique and management. The Thoratec device is a paracorporeal pneumatic pulsatile system configured for univentricular or biventricular support. The device was implanted through a median sternotomy with the use of cardiopulmonary bypass. For left ventricular support, the pump inflow cannula was inserted into the left ventricular apex, and the pump outflow cannula was anastomosed to the ascending aorta. For right ventricular support, the pump inflow cannula was placed into the right atrium or the right ventricle, and the pump outflow cannula was anastomosed to the pulmonary artery. All cannulas were externalized through the anterior abdominal wall and were connected to the left and/or right pump on the anterior surface of the abdomen. Systemic antibiotic prophylaxis (with cefamandole or vancomycin) was initiated during surgery and was continued for 48 h postoperatively.
The dressing at the site of the cannula was changed once every day, until healing was judged satisfactory. The anticoagulation protocol consisted of aspirin and intravenously administered heparin in the immediate postoperative period, followed by orally administered fluindione. All chest drainage tubes and central venous catheters were systematically sent for culture. As soon as the diagnosis of nosocomial infection was strongly suspected, specimens were obtained for culture, and treatment with intravenously administered antibiotics was initiated. Antibiotics specific for isolated microorganisms were continued for an overall treatment duration that was based on the site on the infection and the infecting organism. Surgical treatment of PSM consisted of closed drainage with Redon catheters, as described elsewhere [9] .
Data collection. Hospital records were reviewed retrospectively. Obesity was defined as a preoperative body weight that was 120% of normal body weight, as estimated by the Lorentz formula. Diabetes was defined as the need for medication with an antidiabetic drug. Preoperative renal insufficiency was determined by serum creatinine levels 11.5 mg/dL (1130 mM). Recorded life-threatening complications included device failure, right ventricular failure, chest surgical revision (for postoperative bleeding or pericardial effusion), thromboembolism, renal failure requiring hemodialysis, adult respiratory distress syndrome, septic shock, and occurrence of multiple-organ failure.
Statistical analysis. Statistical analysis was performed by use of SPSS Base 10.0 statistical software (SPSS). Continuous variables were expressed as the mean ‫ע‬ 1 SD or the median (range) and were compared by use of the Wilcoxon 2-sample test. Categorical variables, expressed as percentages, were analyzed by use of Fisher's exact test. Survival data were analyzed by use of the standard Kaplan-Meier actuarial techniques for estimation of probabilities and were compared by use of the log-rank test. To identify risk factors for infection, univariate analysis of preoperative, procedure-related, and postoperative variables was performed by comparing different subsets of patients. To evaluate independent risk factors for infection, significant or marginally significant ( ) univariate risk factors P р .2 were examined by Cox regression analysis. Coefficients were computed by the maximum likelihood method.
(by 2-P ! .05 tailed test) indicated statistical significance. Table 1 shows the clinical characteristics of the patients. Dilated cardiomyopathy was idiopathic in 13 patients, anthracycline induced in 2 patients, and alcohol induced in 1 patient. Before implantation of the device, all patients were experiencing cardiogenic shock and were receiving high-dose inotropic support (dobutamine [for 18 patients], epinephrine [for 18 patients], and therapy with multiple inotropic drugs [for 3 patients]). In addition, 15 of the patients received support with an intra-aortic balloon pump (which was removed after device implantation), and 19 received ventilatory support for severe pulmonary edema. Preoperative and procedure-related variables are presented in table 2.
RESULTS

Patient characteristics.
Infected sites. A total of 99 postoperative episodes of nos- ocomial infection were identified in 31 of 39 patients supported with paracorporeal VAD, for an attack rate of 79.5% and an incidence of 4.9 episodes of infection per 100 support-days. The first episode of infection developed a mean of 9.41 ‫ע‬ days after implantation. The most frequently involved site 12.5 was the lung, with 31 episodes of pneumonia occurring in a total of 23 patients (31.3%). Twenty-six episodes of bloodstream infections (26.2%) were recorded: 14 primary bloodstream infections (involving 10 patients) and 12 secondary bloodstream infections (involving 9 patients). Twenty episodes of cannula infections (20.2%) occurred in a total of 14 patients. Eight urinary tract infections (including 5 cases of catheterassociated infection) occurred in a total of 7 patients. Chest drainage tube infections complicated the clinical course of disease in 7 patients. PSM occurred in 4 patients. One patient experienced 3 episodes of relapsing inguinal soft-tissue infec- 
Pseudomonas aeruginosa - ). P p .26 A total of 19 (48.7%) of 39 patients underwent cardiac transplantation. There was no significant difference between infected and uninfected patients with regard to occurrence of death during receipt of support, weaning from ventricular support, heart transplantation, or development of infection during the 2 weeks after heart transplantation (table 5). 
DISCUSSION
Complications of infection are one of the most important obstacles to the widespread use of VAD. The clinical spectrum of VAD-related infections in the literature varies widely. This is mainly the result of differences in the infection's definition and the type of implanted device [10] . Our study focuses on a homogenous group of patients, all of whom had implantation of the same apparatus performed on an emergency basis. For this group of patients, we report an infection attack rate of 79.5%, for an incidence of 4.9 episodes of infection per 100 support-days. This high incidence can be explained by many factors. First, nosocomial infections (all laboratory confirmed) were defined using criteria from the US Centers for Disease Control and Prevention [6, 7] . This method uses a separate definition for each site and allows for wide recording of all infections that may occur during VAD support. Second, the duration of VAD support is likely to influence the infection rate [11] . Our study included a high proportion of patients receiving long-term support (mean duration of support, 57.8 days). Furthermore, there was a trend toward a longer duration of VAD support among infected patients, compared with uninfected patients (66.9 ‫ע‬ days vs. days; ). 76.0 26.9 ‫ע‬ 34.2 P p .06 As reported by other authors, the most common sites of infection included the lungs, blood, and cannulas [12] . The most frequently isolated organisms included Staphylococcus species and P. aeruginosa. These findings are in agreement with those of Gordon et al. [13] , who found that Staphylococcus species, P. aeruginosa, and Candida species were the organisms most frequently isolated from cultures of blood samples obtained from a series of patients with implantable left VAD.
Risk factors for infection during receipt of ventricular assistance support are related to patient comorbidities and perioperative variables. Many comorbidities have been identified as favoring postoperative infections in cardiac surgery patients, including diabetes, obesity, and chronic obstructive airway disease [14] [15] [16] . Our study did not find any significant difference between infected and uninfected patients for these variables, probably because of the small sample size. However, dilated cardiomyopathy was significantly more frequently noted as underlying cardiac disease in patients with chest drainage tube infections, compared with patients with uninfected chest drainage tubes (6 [85.7%] of 7 patients vs. 10 [30.3%] of 33 patients;
). Dilated cardiomyopathy is a condition characterized P p .013 by long-standing heart failure and is frequently complicated by a moribund state with poor nutrition and a depressed immune system that may favor infection. VAD recipients are often hospitalized for many days or weeks before being referred to the surgical department for device placement. This hospital stay allows nosocomial pathogens to colonize the skin and may facilitate the development of postoperative infections at some skin-related sites.
The group of patients who developed cannula infections had a statistically significant longer preoperative hospital stay than did those without cannula infections ( days vs. 22.5 ‫ע‬ 6.0 days;
). Fischer et al. [17] also reported that 11.6 ‫ע‬ 2.3 P ! .01 infected left VAD recipients spent a greater number of days in the hospital preoperatively than did noninfected patients (14 days vs. 9.5 days); however, the difference was not statistically significant ( ). In a study of risk factors for major sternal P p . 13 wound infection after open-heart surgery, Ottino et al. [18] found that the interval between admission and surgery was 1 of 6 variables that emerged from multivariate analysis as a significant factor ( ); other significant factors included P p .041 blood transfusion ( ), hospital environment ( P p .031 P p ), sternal rewiring ( ), and early chest reexplora-.0001 P ! .0001 tion ( ). P ! .0001 Postoperative bleeding is probably one of the most common events that complicates the course of VAD implantation [19] [20] [21] . Transfusion of blood products can exert several deleterious effects, including exposure to contaminants and immune suppression (decrease in lymphocyte numbers and inhibition of lymphocyte function), thus increasing the risk of postoperative infection in patients undergoing surgical procedures [22] . In this study, transfusion was required significantly more frequently for the infected patients than for the uninfected patients (31 [100%] of 31 patients vs. 6 [75%] of 8 patients;
). Surgical reexploration strongly increases the risk of P p .03 infection in many studies [18, 23, 24] . In fact, surgical wounds and implanted devices are reexposed to pathogens of the surrounding environment during the procedure. Moreover, this condition often implicates the placement of multiple chest drainage tubes, which penetrate the skin barrier and thus constitute a possible route of contamination. In the present report, chest surgical revision is the only independent risk factor for overall postoperative infection identified by multivariate analysis.
In our series, patients with cannula infections experienced significantly more ischemic strokes than did those without infected cannulas ( ). Many reports have pointed out a close rela-P ! .01 tionship between thrombosis and infection in implantable cardiovascular devices [25, 26] . Thrombosis seems to play a key role in the development of infection. In fact, thrombus components, particularly fibrin and fibrinogen, increase bacterial adhesion on artificial surfaces [27, 28] . In addition, bacteria embedded within thrombi may be protected from the normal host defense mechanisms and antimicrobials [10] . Reciprocally, endotoxins and inflammatory cells involved in the infective process can promote platelet aggregation and thromboembolism [29] .
In this series, there were no significant differences between infected patients and uninfected patients with regard to occurrence of death during receipt of ventricular support, weaning from ventricular support, the need for heart transplantation, and the development of infections after heart transplantation. The effect of infection on the survival of VAD recipients is not controversial in the literature. Herrmann et al. [30] , in a prospective evaluation of 25 patients bridged to heart transplantation with the Novacor N 100 portable left VAD (Edwards), found a survival rate of 42% for patients with VAD infection versus 85% for patients without infection ( ). P ! .05 However, many other reports did not find an influence of infection on overall survival [12, 31, 32] . In all these studies, infection did not preclude heart transplantation or alter the survival rate after transplantation [12, [30] [31] [32] . In addition, there was no statistically significant difference between infected and uninfected VAD recipients regarding complications of infection that occur after transplantation [31, 32] .
In conclusion, in our series, paracorporeal VAD support was associated with a high incidence of complications of infection, mainly involving the blood and lungs and chiefly due to Staphylococcus species. Multivariate analysis revealed chest surgical revision to be the only independent risk factor for overall postoperative infection. We found no significant influence of infection on the heart transplantation rate and overall survival. Reduction of complications of infection among VAD recipients necessitates a diverse approach to control many of the known risk factors. Further studies are needed to evaluate prevention strategies, especially in light of plans to use these devices as a permanent alternative to transplantation.
